Genome- and Transcriptome-Wide Mapping of Alternative Nucleic Acids

From Structural Maps to Biomarkers and Therapy

Comprehensive structural maps could have applications extending beyond fundamental biology. If particular nucleic acid conformations are reproducibly associated with specific cellular or disease states, they could potentially serve as molecular biomarkers. Structural signatures might help classify disease subtypes, identify biologically distinct patient populations, or provide pharmacodynamic indicators of responses to therapies that alter transcription, chromatin, replication, or RNA metabolism.

More importantly, mapping provides a foundation for identifying druggable structural vulnerabilities.

Most conventional drug-development strategies target proteins. However, nucleic acids themselves possess complex three-dimensional surfaces capable of interacting with small molecules and proteins. Alternative DNA and RNA conformations may therefore represent an underexplored class of pharmacological targets. Once disease-associated structures are identified, therapeutic strategies could potentially be designed to stabilize, destabilize, induce, prevent, or otherwise modulate specific nucleic acid conformations.

For example, stabilizing a particular structure could enhance a beneficial cellular response, whereas destabilizing a pathogenic structure could restore normal transcription, replication, or RNA metabolism. Alternatively, compounds could interfere with the proteins that recognize, generate, or resolve these structures. Such approaches would establish a new therapeutic framework in which nucleic acid conformation itself becomes a pharmacologically addressable biological variable.

Cancer may provide an especially compelling opportunity. Tumor cells frequently contain abnormalities in genome stability, transcriptional regulation, RNA processing, and innate immune signaling. Structural mapping could identify alternative nucleic acid conformations selectively enriched in tumor cells and reveal pathways upon which tumors depend for managing these structures. These dependencies could potentially expose therapeutic vulnerabilities while also providing opportunities to manipulate tumor-intrinsic immune signaling.

The concept could also support combination therapies. Drugs targeting nucleic acid structural states might potentially complement immunotherapies, DNA-damage response inhibitors, epigenetic therapies, targeted therapies, or conventional anticancer agents. However, these possibilities require rigorous experimental validation to establish selectivity, biological causality, safety, and therapeutic benefit.

Revealing a Structural Layer of Genome Regulation

One of the most important applications of alternative nucleic acid mapping is understanding how DNA structure contributes to genome regulation. Formation of non-B-DNA structures can influence interactions between nucleic acids and transcription factors, chromatin regulators, DNA repair machinery, replication complexes, and other regulatory proteins. Structural transitions may therefore participate in processes including transcription, replication, recombination, DNA damage responses, and chromatin organization.

Importantly, these structures are often dynamic. A genomic region may predominantly exist as canonical B-DNA under one condition but transition toward an alternative conformation following transcription, cellular stress, changes in chromatin state, or altered DNA topology. Mapping these structural transitions across the genome could therefore provide information that cannot be obtained from DNA sequence alone.

The same principle extends to the transcriptome. RNA structure strongly influences interactions with RNA-binding proteins and can affect RNA stability, localization, translation, processing, degradation, and innate immune recognition. Transcriptome-wide structural maps could reveal populations of RNAs that adopt unusual conformations and identify cellular pathways associated with their formation or resolution.

Together, genome- and transcriptome-wide structural maps could establish an atlas of nucleic acid conformational states, enabling researchers to integrate structural information with genomic, epigenomic, transcriptomic, and proteomic datasets. This multidimensional view could substantially improve our understanding of how nucleic acids function inside living cells.

What is Alternative Nucleic Acid Structures

The genome and transcriptome are commonly represented as collections of linear nucleotide sequences. However, DNA and RNA are not static molecules. Their sequences can adopt a diverse range of three-dimensional conformations that coexist with, or transiently replace, canonical B-form DNA and conventional RNA structures. These alternative nucleic acid structures add an important structural dimension to genome and transcriptome biology and have the potential to influence how genetic information is stored, accessed, expressed, and sensed by cells.

Alternative DNA structures include Z-DNA, G-quadruplexes (G4s), triplex DNA, cruciforms, hairpins, and other non-B-DNA conformations. RNA molecules exhibit an even broader structural repertoire, including Z-RNA, RNA G-quadruplexes, stem-loops, pseudoknots, and complex higher-order structures. Formation of these structures can depend on nucleotide sequence, transcriptional activity, supercoiling, RNA modification, molecular crowding, interactions with proteins, and the local biochemical environment. Consequently, the structural state of a nucleic acid may change dynamically even when its underlying sequence remains unchanged.

Genome- and transcriptome-wide mapping of alternative nucleic acids seeks to determine where these structures occur, when they form, and how their distribution changes between biological states. Such maps have the potential to provide a new layer of biological information beyond conventional genome sequencing, epigenomics, and transcriptomics. Instead of asking only what sequence is present or how much RNA is expressed, structural mapping introduces another fundamental question: what physical conformation does a particular region of DNA or RNA adopt inside the cell?

Alternative Nucleic Acid Structures and Disease

The biological importance of alternative nucleic acid structures becomes particularly relevant when their formation or regulation is disrupted. Abnormal nucleic acid structures can potentially interfere with replication, transcription, DNA repair, RNA metabolism, and cellular signaling. Consequently, altered structural landscapes may be associated with pathological states.

In cancer, for example, cells experience profound changes in transcription, replication stress, genome stability, chromatin organization, and RNA metabolism. Each of these processes can potentially influence the formation of alternative DNA and RNA structures. Mapping these structures across tumor and normal cells could identify cancer-associated structural signatures and reveal genomic regions or transcripts whose conformational states are selectively altered during malignant transformation.

Alternative nucleic acid structures are also particularly relevant to innate immunity. Cells possess specialized proteins capable of detecting unusual nucleic acids as indicators of infection or cellular damage. Certain DNA and RNA conformations can therefore function as molecular danger signals. Z-form nucleic acids provide an important example: Z-DNA and Z-RNA are recognized by specialized Zα-domain-containing proteins, connecting nucleic acid conformation with antiviral immunity, inflammation, and programmed cell-death pathways.

Structural dysregulation may also contribute to neurological, inflammatory, infectious, and genetic diseases. Repetitive sequences, expanded nucleotide repeats, highly transcribed genomic regions, and regions undergoing substantial topological stress can have unusual structural properties. Determining whether particular alternative conformations are enriched in disease-associated genomic loci could help distinguish structures that are merely correlated with disease from those that actively contribute to disease mechanisms.

A major opportunity is therefore to compare structural nucleic acid landscapes between healthy and diseased states. Similar to differential gene-expression analysis, researchers could eventually perform differential structural analysis to identify regions that gain or lose specific nucleic acid conformations during disease progression, treatment, aging, infection, or cellular stress.

Building a Structural Genomics and Transcriptomics Framework

The broader objective of genome- and transcriptome-wide mapping of alternative nucleic acids is therefore not simply to catalogue unusual structures. It is to establish a framework connecting nucleic acid sequence, structure, biological function, disease, and pharmacology.

Sequence → Structure → Molecular interactions → Cellular function → Disease association → Therapeutic opportunity

Within such a framework, genome-wide maps can identify where alternative structures occur; transcriptome-wide maps can reveal their distribution across cellular RNAs; functional studies can determine their biological consequences; and disease comparisons can identify structures associated with pathological states. These discoveries can subsequently guide the identification of biomarkers, therapeutic targets, and compounds capable of manipulating nucleic acid structural dynamics.